Cargando…
Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
Correction to " Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer" World J Clin Cases 2019; 7(15): 1964-1977. In this article, one of the affiliation of the first author was lacke...
Autores principales: | Kaito, Akio, Kuwata, Takeshi, Tokunaga, Masanori, Shitara, Kohei, Sato, Reo, Akimoto, Tetsuo, Kinoshita, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674736/ https://www.ncbi.nlm.nih.gov/pubmed/33269289 http://dx.doi.org/10.12998/wjcc.v8.i21.5494 |
Ejemplares similares
-
Epidermal Growth Factor Stimulates Transforming Growth Factor-Beta Receptor Type II Expression In Corneal Epithelial Cells
por: Shu, Daisy Y., et al.
Publicado: (2019) -
Epidermal Growth Factor‐dependent Dissociation of CrkII Proto‐oncogene Product from the Epidermal Growth Factor Receptor in Human Glioma Cells
por: Katayama, Haruko, et al.
Publicado: (1999) -
Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
por: Park, Sojung, et al.
Publicado: (2021) -
Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004) -
Epidermal growth factor receptor in glioblastoma
por: Xu, Hongsheng, et al.
Publicado: (2017)